SOURCE:
http://www.jweekly.com/article/full/72888/israelis-respond-to-ebola-with-preparedness-innovation
EXCERPT:
Scientists working on Ebola treatments may soon be looking to Israeli-owned pharmaceutical company CollPlant, reports the Times of Israel.
The company uses tobacco plants to manufacture human proteins, which are used in Zmapp, the only Ebola treatment on the horizon.
The company’s founder, Oded Shoseyov, is optimistic that CollPlant could assist in curbing the spread of the deadly virus. “We didn’t invent the method, but we have taken it farther than anyone else,” he told the newspaper.
None of that cut/paste makes ZMapp a ‘vaccine’.
It’s a treatment.
It works AFTER you’ve been infected. Vaccines work BEFORE you’ve got active infection.
Totally different things.